Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Matthay

Showing results (141-150 of 316) with videos related to

Pageof 32
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2001
Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBGH R Tang, A J Da Silva, K K Matthay, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|October 1, 1991
Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastomaK K Matthay, J P Huberty, R S Hattner, et al.
Biochimica Et Biophysica Acta|April 13, 1992
Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomesM C Woodle, K K Matthay, M S Newman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastomaKatherine K Matthay, Veronique Edeline, Jean Lumbroso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studiesD O Stram, K K Matthay, M O'Leary, et al.
Pediatric Blood & Cancer|December 20, 2011
Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcomaJeremy M Sharib, Jobin Cyrus, Andrew Horvai, et al.
Pediatric Blood & Cancer|October 18, 2021
Anatomic patterns of relapse and progression following treatment with <sup>131</sup> I-MIBG in relapsed or refractory neuroblastomaRotem Fishel Ben Kenan, Alexei L Polishchuk, Randall A Hawkins, et al.
Medical Physics|February 15, 2019
Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for <sup>131</sup> I-MIBG therapy of neuroblastoma using <sup>124</sup> I-MIBG PET/CTYoungho Seo, Yoonsuk Huh, Shih-Ying Huang, et al.
British Journal of Cancer|April 30, 2009
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task ForceK Beiske, S A Burchill, I Y Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paragangliomaSara Gonias, Robert Goldsby, Katherine K Matthay, et al.
Pageof 32

Showing results (141-150 of 316) with videos related to

Sort By:
Pageof 32
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2001
Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBGH R Tang, A J Da Silva, K K Matthay, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|October 1, 1991
Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastomaK K Matthay, J P Huberty, R S Hattner, et al.
Biochimica Et Biophysica Acta|April 13, 1992
Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomesM C Woodle, K K Matthay, M S Newman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastomaKatherine K Matthay, Veronique Edeline, Jean Lumbroso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studiesD O Stram, K K Matthay, M O'Leary, et al.
Pediatric Blood & Cancer|December 20, 2011
Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcomaJeremy M Sharib, Jobin Cyrus, Andrew Horvai, et al.
Pediatric Blood & Cancer|October 18, 2021
Anatomic patterns of relapse and progression following treatment with <sup>131</sup> I-MIBG in relapsed or refractory neuroblastomaRotem Fishel Ben Kenan, Alexei L Polishchuk, Randall A Hawkins, et al.
Medical Physics|February 15, 2019
Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for <sup>131</sup> I-MIBG therapy of neuroblastoma using <sup>124</sup> I-MIBG PET/CTYoungho Seo, Yoonsuk Huh, Shih-Ying Huang, et al.
British Journal of Cancer|April 30, 2009
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task ForceK Beiske, S A Burchill, I Y Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paragangliomaSara Gonias, Robert Goldsby, Katherine K Matthay, et al.
Pageof 32